PBCAR20A

DB17189InvestigationalCell transplant therapies

PBCAR20A: Overview.

Also known as
Allogeneic anti-CD20 CAR T cells
Code names
PBCAR 20A

What you can answer from here — as of September 25, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of PBCAR20A, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In